| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(99)00398-9 |
| P698 | PubMed publication ID | 10618535 |
| P2093 | author name string | Moormann RJ | |
| Bouma A | |||
| De Jong MC | |||
| De Kluijver EP | |||
| De Smit AJ | |||
| P2860 | cites work | Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera | Q27486212 |
| On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations | Q34155650 | ||
| Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus | Q40639488 | ||
| Subdivision of the pestivirus genus based on envelope glycoprotein E2. | Q40645179 | ||
| Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge | Q40662007 | ||
| An enzyme immunoassay employing monoclonal antibodies and detecting specifically antibodies to classical swine fever virus | Q40786165 | ||
| The protective value of vaccine-induced neutralising antibody titres in swine fever | Q40788758 | ||
| Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis | Q40807127 | ||
| Molecular cloning and nucleotide sequence of hog cholera virus strain Brescia and mapping of the genomic region encoding envelope protein E1. | Q41729468 | ||
| Recombinant polypeptide from the gp48 region of the bovine viral diarrhea virus (BVDV) detects serum antibodies in vaccinated and infected cattle | Q42982329 | ||
| An ELISA detecting antibody to conserved pestivirus epitopes. | Q42985801 | ||
| An experimental infection with classical swine fever virus in weaner pigs. I. Transmission of the virus, course of the disease, and antibody response | Q42987626 | ||
| Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity | Q44028815 | ||
| Experimental quantification of vaccine-induced reduction in virus transmission | Q45780125 | ||
| The computation of R0 for discrete-time epidemic models with dynamic heterogeneity. | Q51652282 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | classical swine fever virus | Q683770 |
| classical swine fever | Q19000581 | ||
| P304 | page(s) | 1374-1381 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus | |
| P478 | volume | 18 |
| Q40313229 | A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever |
| Q30355944 | A promising multiple-epitope recombinant vaccine against classical swine fever virus. |
| Q38697809 | A single dose of the novel chimeric subunit vaccine E2-CD154 confers early full protection against classical swine fever virus |
| Q54644855 | An experimental model to quantify horizontal transmission of Mycoplasma gallisepticum. |
| Q47147214 | Animal health safety of fresh meat derived from pigs vaccinated against Classic Swine Fever |
| Q40310279 | Characterization of the monoclonal antibody against classical swine fever virus glycoprotein E(rns) and its application to an indirect sandwich ELISA. |
| Q40609315 | Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs |
| Q30234718 | Classical Swine Fever-An Updated Review |
| Q40596608 | Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISAs |
| Q40554097 | Comparison of antibody values in sera of pigs vaccinated with a subunit or an attenuated vaccine against classical swine fever |
| Q47146243 | Control and eradication of Classic Swine Fever in wild boar |
| Q64981042 | Development of Recombinant Protein-Based Vaccine Against Classical Swine Fever Virus in Pigs Using Transgenic Nicotiana benthamiana. |
| Q40403499 | Development of a live attenuated antigenic marker classical swine fever vaccine. |
| Q33335898 | Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination |
| Q40383594 | Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats. |
| Q40428147 | Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus |
| Q40587942 | Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. |
| Q73067904 | Experimental quantification of the transmission of Sarcoptes scabiei var. suis among finishing pigs |
| Q42210742 | Extended transmission of two H5/H7 low pathogenic avian influenza viruses in chickens. |
| Q35242493 | Generation and efficacy evaluation of recombinant classical swine fever virus E2 glycoprotein expressed in stable transgenic mammalian cell line |
| Q73636871 | Herd immunity after vaccination: how to quantify it and how to use it to halt disease |
| Q39646385 | Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs |
| Q89530641 | Identification of E2 with improved secretion and immunogenicity against CSFV in piglets |
| Q57584130 | Inference in disease transmission experiments by using stochastic epidemic models |
| Q34087342 | Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review |
| Q90260409 | Lentiviral-mediated delivery of classical swine fever virus Erns gene into porcine kidney-15 cells for production of recombinant ELISA diagnostic antigen |
| Q40469761 | Limited BVDV transmission and full protection against CSFV transmission in pigs experimentally infected with BVDV type 1b. |
| Q36578325 | Marker vaccine strategies and candidate CSFV marker vaccines |
| Q33726680 | Modelling the effectiveness and risks of vaccination strategies to control classical swine fever epidemics |
| Q59357240 | Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever |
| Q34341579 | Present and future of veterinary viral vaccinology: a review |
| Q40404734 | Quantification of classical swine fever virus in aerosols originating from pigs infected with strains of high, moderate or low virulence. |
| Q40179766 | Quantification of different classical swine fever virus transmission routes within a single compartment. |
| Q40547483 | Quantification of the effect of control strategies on classical swine fever epidemics |
| Q40607316 | Secretory pathway limits the enhanced expression of classical swine fever virus E2 glycoprotein in insect cells |
| Q37658883 | Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza |
| Q26860412 | Structures and Functions of Pestivirus Glycoproteins: Not Simply Surface Matters |
| Q35004568 | Swine fever: classical swine fever and African swine fever |
| Q38161261 | The challenges of classical swine fever control: modified live and E2 subunit vaccines |
| Q44648563 | The impact of viral tropism and housing conditions on the transmission of three H5/H7 low pathogenic avian influenza viruses in chickens. |
| Q53505792 | The use of vaccines to control pathogen spread in pig populations. |
| Q51743820 | Towards the development of a one-dose classical swine fever subunit vaccine: antigen titration, onset and duration of immunity. |
| Q41407720 | Transmission characteristics and optimal diagnostic samples to detect an FMDV infection in vaccinated and non-vaccinated sheep |
| Q40628258 | Transmission of classical swine fever virus within herds during the 1997-1998 epidemic in The Netherlands |
| Q45731009 | Transmission of encephalomyocarditis virus (EMCV) among pigs experimentally quantified |
| Q40407514 | Vaccination against foot and mouth disease reduces virus transmission in groups of calves. |
| Q35672385 | Vaccination of influenza a virus decreases transmission rates in pigs |
| Q45656595 | Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus |
| Q36601830 | Vaccines for viral and parasitic diseases produced with baculovirus vectors |
| Q35576473 | Vaccinology of classical swine fever: from lab to field |
| Q39402612 | Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission |
| Q40384137 | Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response |
Search more.